[Special Stock] Solux, Aribio's 1.2 Trillion Won Contract Valid... Partial Payment of Second Contract Deposit Made Quickly Increasingly

Sorux is showing strong performance. This is interpreted as being influenced by the announcement that the second contract payment with Aribio and its Chinese partner company is proceeding without any issues.

As of 1:53 PM on the 13th, Sorux is trading at 3,550 KRW, up 16.58% compared to the previous day.

The day before, Sorux stated, "Aribio has continuously requested the Chinese partner company to make the second contract payment without any delays, and recently, as the payment deadline approached, we strongly urged the deposit."

They added, "We received feedback from the Chinese side to review the signed contract again, and accordingly, the person in charge of preparing the securities report re-examined the contract submitted to the Financial Supervisory Service."

According to this, the second contract payment date is not 200 business days from the clinical approval plan (IND) approval date stated in the Sorux securities report (March 7, 2025), but rather within 200 business days from the first contract payment receipt date (October 8, 2024) as specified in the actual contract (July 28, 2025).

Sorux stated, "Regarding the second contract payment in China, although the Chinese partner company’s second payment deadline has not yet arrived, they have promised partial and continuous payments to our company to cooperate with the parent company's smooth global clinical progress in the sales rights contract, and a portion of the second contract payment will be deposited soon."